News
Parse Biosciences to Participate in Canaccord Genuity Investor Conference
MEDIA ADVISORY CEO and co-founder Alex Rosenberg, Ph.D. joining panel discussion at November 17 event in New York WHAT:Senior executives from Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, will participate in the Canaccord Genuity Medtech, Diagnostics and Digital Health & Services Forum. The one-day event will profile public and […]
Read MoreParse Biosciences Announces Cloud Analysis Platform to Simplify Single Cell Analysis
New Platform to Lower Barriers to Adoption of Single Cell RNA Sequencing. ASHG Annual Meeting, Los Angeles, CA, October 26, 2022 – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a new cloud analysis solution to simplify the analysis of single cell RNA sequencing (scRNA-seq). The new cloud […]
Read MoreParse Biosciences Releases Whole Transcriptome Version 2 Chemistry with Marked Performance Enhancements
Newly released Evercode™ Whole Transcriptome v2 kits have demonstrably improved gene detection and robustness. SEATTLE, August 30, 2022 – Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, announced today a significant performance update of its chemistry for the Evercode™ Whole Transcriptome products. With substantial gains in transcript and gene detection […]
Read MoreParse Biosciences Announces Partnership with Molecular Diagnostics Korea
With products now available in South Korea, partnership broadens access to single cell genomics research in Asia Seattle, WA. (June 6, 2022) – Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular Diagnostics Korea (MDxK) that will expand its presence in Asia by providing its entire line of […]
Read MoreParse Bio Pools Further Funding
Parse Biosciences Announces Partnership With Research Instruments Group to Offer scRNA-Seq Kits in Singapore and Southeast Asia Region
Previously available in North America, Europe, Australia and New Zealand, partnership to further accelerate single cell genomics research in the APAC region Seattle, WA, January 18, 2022 Parse Biosciences, a company providing researchers with single-cell sequencing solutions, today announced a partnership with Research Instruments Pte Ltd to provide Parse’s Evercode Whole Transcriptome Kits (WTKs), Cell Fixation Kits […]
Read More